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Summary 
The p55 tumor necrosis factor (TNF) receptor and Fas/APO1 induce cell death via distinct re- 
gions in their intracellular domains. Three cytoplasmic proteins that bind to these receptor re- 
gions have been identified recently.  One, MORT1  (also  called FADD), binds to Fas/APO1 
but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; 
and the third, RIP, binds weakly to both receptors. The regions within these proteins that are 
involved in binding to the receptors and the receptor regions to which they bind share a com- 
mon sequence motif, that of the "death domain." This study shows that the death domain mo- 
tifs in MORT1, TRADD, and RIP bind effectively to each other, a mode of binding that may 
allow "cross-talk" between the functional expression of the p55 TNF receptor and Fas/APO1. 
T 
he p55 TNF receptor (p55-R) and Fas/APO1 are struc- 
turally related and activated by distinct yet structurally 
related ligands, which share the ability to induce death in cells. 
The physiological roles of these receptors are different. The 
ligand molecules activating the p55-R are mainly formed by 
mononuclear phagocytes, and cell death induction by the re- 
ceptor occurs as part of a wide repertoire of other induced 
functional changes, most of which are involved in the in- 
flanunatory process (1, 2). Fas/APO1 activation, on the other 
hand,  occurs in response to a lymphocyte-produced ligand 
and apparently leads almost solely to cell death (3). There seem 
also  to be differences in the  mechanisms of cell death in- 
duction by p55-R and Fas/APO1.  They are manifested in 
different  morphological  features  of the  death  processes. 
Also, the death processes occur synergistically, induced dif- 
ferentially in  cells of different lines  and modulated differ- 
ently by drugs and biological regulators  (4--6). Yet there  is 
also  evidence that cell death induction by p55-R and Fas/ 
APO1 involves similar, or even common, mechanisms, both 
in  the  early  and  late  events  of the  death  induction  pro- 
cesses. The structural requirements for the induction of cell 
death by the two receptors reside in intracellular domain re- 
gions  that  have  sequence  homology;  in  both  receptors, 
these  regions  (called  the  "death  domains")  tend  to  self- 
associate, which apparently contributes to the initiation of 
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their signaling (7-10). Cell death induction by both recep- 
tors involves a critical function ofprotease(s) related to the 
IL-1 B-converting enzyme (ICE) (11-14), and both can be 
suppressed in a cell type-specific manner by BCL2 (15,  16). 
The mechanistic level at which the interaction between the 
signaling by p55-R and Fas/APO1 occurs, and how this in- 
teraction results in the observed similarities and differences 
in their effects, have not been documented. 
Three  cytoplasmic proteins--MORT1  (17)  (or FADD 
[18]),  RIP (19),  and TR.ADD (20)--that bind to the intra- 
cellular  domains  of p55-R  or  Fas/APO1  and  apparently 
take  part  in  the  induction  of their  cytocidal  effect have 
been cloned recendy. All these proteins were found to con- 
tain the sequence motif shared between the death domains 
(DD)  of the intracellular domains of p55-R and Fas/APO1. 
As in the receptors, the DD motifs in the three cytoplasmic 
proteins seem to be sites of protein-protein interaction. The 
three proteins interact with the p55-R and Fas/APO1  in- 
tracellular domains by the binding of their DDs to those in 
the receptors, and in both TRADD and RIP (though not 
in MOtLT1)  the DDs self-associate. In this study,  we ex- 
plored further the associations among the three cytoplasmic 
proteins and the two receptors resulting from their DD in- 
teractions. MORT 1 and TRADD were found to bind dif- 
ferentially to Fas/APO1  and p55-R, but also to each other, 
and both bound effectively to RIP. This mode of binding 
may allow for functional "cross-talk" between p55-R and 
Fas/APO1 early in their signaling cascades. 
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Two-hyDid ~-Galactosidase Expression  Tests.  cDNA  inserts  were 
cloned by PCR, either from the fifll-length cDNAs cloned previ- 
ously in our laboratory or from purchased cDNA libraries.  Residue 
numbering in the proteins encoded by the cDNA inserts are as in 
the Swiss-Prot Data Bank. Point mutants were produced by oli- 
gonucleotide-directed mutagenesis  (21).  13-galactosidase  expres- 
sion in yeasts  (SFY526 reporter strain [22]) transformed with these 
cDNAs in the pGBT-9 and pGAD-GH vectors  (DNA binding 
domain [DBD]  and activation domain lAD]  constructs,  respec- 
tively) was assessed  by a  filter assay  (10)  When expressed in the 
pGAD-GH vector, RIP and its DD had some cytotoxic effect on 
the yeasts,  manifested in a low yield of yeast colonies. They did 
not have  any such  cytotoxic  effect  when expressed  (to  a  lower 
extent) in the pGBT-9 vector. 
Induced  Expression,  Metabolic  Labeling,  and Immunoprecipitation  of 
Proteins.  Since the size similarity of the DDs makes it difficult to 
distinguish between them in gel electrophoresis, we chose to ex- 
amine the interaction of MORT1, TRADD and RIP by coexpress- 
ing the full-length MORT1  protein with the DDs of TRADD 
and RIP. The proteins, N-linked to the FLAG octapeptide (East- 
man Kodak Co., New Haven, CT), or to an influenza hemagglu- 
tinin (HA) epitope CYPYDVPDYA [23]) were expressed in HeLa 
cells using a tetracycline-controlled expression vector and labeled 
metabolically with [35S]Met (55  I~Ci/ml) and [3sS]Cys (10 IxCi/ 
1111) (EXPRE35S35S protein labeling mix; DuPont, Wilmington, 
DE), as described before (17).  The cells were then lysed in RIPA 
buffer (1 ml/5 ￿  105 cells), and the lysates were precleared by in- 
cubation with irrelevant rabbit antiserum (3  Ixl/ml) and protein 
G-Sepharose beads (Pharmacia, Uppsala, Sweden; 60 pJ/ml). Im- 
munoprecipitation was  performed by  1-h incubation at  4~  of 
0.3-ml allquots  of lysate  with  mouse  mAbs  (5  I~g per aliquot) 
against the  FLAG octapeptide  (M2;  Eastman Kodak  Co.),  HA 
epitope  (12CA5  [23]),  or the p75  TNF receptor  (#9;  [24])  as a 
control, followed by an additional 1-h incubation with protein 
G-Sepharose beads (30 Ixl per aliquot). The immunoprecipitates 
were  washed  three  times  with  REPA  buffer and  analyzed by 
SDS-PAGE. 
Results 
The  interactions  of  the  DDs  of human  p55-R,  Fas/ 
APO1,  TRADD,  MORT1,  and RIP  were  evaluated first 
by  a  yeast  two-hybrid  test.  The  CDNAs  encoding these 
domains were  expressed  as  fusion proteins  with  the  Ga14 
DNA  binding and activation domains (DBD and AD con- 
structs) in the yeast SFY526 reporter strain, and the binding 
of these fusion proteins to each other was assessed by deter- 
Figure  1.  Interactions  of the DDs  of p55-R,  Fas/APO1,  MORT1, 
TRADD, and RIP in a yeast two-hybrid test, and the effect of lpr~g-like 
mutations in these proteins on their interactions. Assessment of the inter- 
action of Ga14 hybrid constructs encompasses the following human pro- 
teins truncated upstream to their DD motifs: p55-R (residues 326-426), 
Fas/APO1  (residues 210-319),  MORT1  (residues 92-208),  TRADD 
(residues 195-312), and RIP (residues 261-372), as well as of the follow- 
ing point mutants of these proteins: p55-R L351N,  Fas/APO1  V238N, 
MORT1 V121N, and RIP F308N, whose mutation sites within the DDs 
correspond to that found in the Fas/APO1 of the Ipr  cg mice. Each cDNA 
insert was introduced both into the Ga14 DBD and the Ga14 AD con- 
structs (pGBT9 and pGAD-GH), and the binding  of inserts in both con- 
structs to all other inserts within transfected SFY526 yeasts was assessed by 
a 13-galactosidase  expression filter assay. The results are presented in ternrs 
of the time required for development of  strong color. ND, not done. 
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of the DD interactions observed in the 
yeast two-hybrid tests. The lengths and 
thicknesses of the arrows connecting the 
DD icons correspond to the intensity of 
the interactions as observed in the  ex- 
periment described in Fig. 1. 
mining [3-galactosidase expression by the yeasts. The results 
of these tests are summarized in Fig.  1  and illustrated dia- 
grammatically in Fig. 2. 
The DDs ofp55-R, Fas/APO1, TRADD,  and RIP were 
able to self-associate. The DD of MORT1  lacked this abil- 
ity, even though the full-length MORT1  protein does self- 
associate  (17),  apparently through  an  interaction  that  in- 
volves the region upstream of its DD. 
The  DD  of TRADD  bound to  the  DD  of p55-R,  but 
not to the DD of Fas/APO1, whereas the DD ofMOR, T1 
behaved in the converse fashion. 
The  DD  of RIP,  like the  full-length RIP  protein  (19, 
was able to bind both to the DDs of Fas/APO1 and p55-R. 
Binding was significantly weaker,  though,  than that of the 
DDs of TRADD  or MORT1  to these receptors. Although 
RIP  was  initially identified by virtue  of its  binding  in  a 
two-hybrid  screen  to  Fas/APO1  (19),  this  binding  was 
quite weak, and could be observed only when the RIP DD 
was highly expressed in the yeasts, by introducing it into the 
AD construct. There was no measurable binding when the 
DD of RIP was introduced into the DBD construct, which 
has a lower expression effectivity. A longer RIP insert, cor- 
responding to amino acids 161-372 in the protein, did not 
bind more effectively to Fas/APO1  (not shown). 
Apart from their observed binding to the DDs of p55-R 
or  Fas/APO1,  the  DDs  of each  of the  three  cytoplasmic 
proteins tested bound also to each other. These interactions 
were all effective. Notably, the effectivity of binding of the 
DD of RIP to the DDs of MORT1  and TRADD  was sig- 
nificandy greater  than  that  of its  binding  to  the  DDs  of 
p55-R and Fas/APO1. 
A  similar pattern of interaction was observed in the HF7c 
yeast reporter  strain,  regularly used  in  our  laboratory for 
two-hybrid screens.  Indeed,  in  a  recent  attempt  to  clone 
proteins that bind to MORT1  by a two-hybrid screen, we 
found  that  a  significant proportion  of the  cloned  cDNAs 
encode TRADD  or RIP (not shown). 
In specificity tests for the two-hybrid assay, we  did not 
observe binding of the DD motifs to any of a number of ir- 
relevant proteins, including SNF1, the intracellular domain 
Figure 3.  Interactions of MORT1, TRADD, and RIP within transfected HeLa cells. MORT-1 (nucleotides 19-753 in GenBank accession number 
U24231), fused at its NH  2 terminus with the FLAG octapeptide, and the DDs of TRADD (amino acids 195-312) and of RIP (amino acids 261-372), 
fused at their NH  2 termini either with the FLAG octapeptide or the HA epitope (23), were expressed, either alone or in mixtures of two in HeLa cells, 
and metabolically  labeled with [35S]Cys  and [3SS]Met. Cross-immunoprecipitation of  the coexpressed  proteins was performed using the indicated antibod- 
ies. The proteins were analyzed by SDS-PAGE (15% acrylamide)  followed by autoradiography. In cell lysates  containing MORT1 and RIP, coimmuno- 
precipitation of  both proteins could be obtained using antibodies against  either one of them. However, in lysates  containing TRADD and RIP, coimmu- 
noprecipitation of the two proteins was observed only when  using antibody against RIP, and in lysates containing TRADD and MORT1,  it was 
observed only with an antibody against TRADD, apparently because ofsteric hindrance. 
1273  Varfolomeev et al.  Brief  Definitive Report of the human p75 TNF receptor, lamin, cyclin D, and the 
DD of the rat low-a~nity nerve growth factor (NGF) re- 
ceptor (not shown). To further assess the binding specificity, 
we introduced point mutations to the p55-R,  Fas/APO1, 
MORT1, and RIP DDs at sites  corresponding to that of 
1-225  in  the mouse Fas/APO1  sequence.  A  naturally oc- 
curring replacement mutation of this residue, found in lpr cg 
mice, abolishes  signaling by Fas/APO1  (9, 25) as well as its 
interaction with MORT1  (17,  18). Mutation of the corre- 
sponding residues in the DDs of human p55-R (L351N) and 
Fas/APO1 (V238N) had a similar effect.  The mutated pro- 
teins were not able to self-associate, nor to bind to TRADD, 
MORT1, or RIP. Also, introduction of a replacement mu- 
tation to the DD of  RIP at the site corresponding to that of 
the  lpr  cg mutation (F308N)  resulted in loss of its ability to 
bind to Fas/APO1, MORT1, and TRADD, as well as to self- 
associate,  although the  mutated protein still bound to the 
normal  RIP  DD.  On  the  other  hand,  in  MORT1,  the 
lprcg-like  mutation (V121N) had only a limited effect. It re- 
sulted in less effective binding to Fas/APO1, which, for some 
reason, was observed only when the mutated protein was in- 
troduced into the AD construct but not in the DBD con- 
struct. 
To  test  whether  the  interactions  observed  between 
TRADD, MORT1, and RIP in the yeast two-hybrid tests 
occur also in eukaryotic cells, we coexpressed MORT1 and 
the DDs of TRADD and RIP within transfected HeLa cells 
and attempted to immunoprecipitate them from the cell ly- 
sates.  Immunoprecipitation resulted in precipitation of the 
coexpressed proteins, indicating that they bind to each other 
within the HeLa cells (Fig. 3). 
Discussion 
Although the evidence is still largely indirect,  TRADD, 
MORT1,  and RIP appear to play important roles  in  the 
initiation  of the  cytocidal effect of p55-R and Fas/APO1 
(26). The binding of these proteins to the receptors, which 
occurs through their DDs, apparently is required for their 
contribution to the signaling.  A recent study showing that 
stimulation  of  Fas/APO1 in cells evokes binding of  MORT1 
to this receptor suggests that the DD interactions observed 
within transfected yeasts occur also within the mammalian 
cell, and take part in the process of  signaling induction (27). 
Although  the  DDs  of all  the  proteins  examined  in  this 
study have the ability to bind to other DDs, there is clear 
specificity in this interaction. The DD of TRADD binds to 
that ofp55-R, but not to the DD of Fas/APO1. The DD 
of MORT1  binds to the DD of Fas/APO1, but does not 
bind to the DD ofp55-R. This specificity in the action of 
proteins  that  take  part  in  the  signaling activity of p55-R 
and Fas/APO1 may well contribute to the differences in func- 
tion of the two receptors. 
In addition  to  their  differential  binding to  the  DDs  of 
p55-R and Fas/APO1, the DDs of TRADD and MORT1 
also are able to bind effectively to each other, and both are 
capable of  binding to the DD of RIP more effectively than 
do the DDs of Fas/APO1  or p55-R.  Thus,  even though 
distinct,  the  signaling  cascades  affected  by  TRADD  and 
MORT1 may well be coordinated through their mutual in- 
teractions.  The nature of  this coordination may vary, depend- 
ing on the way in which the  different interactions  of the 
DD in a given protein affect each other. These interactions 
may occur together or be exclusive; they may also modu- 
late  each other.  One possible  way for such modulation is 
indicated  by  the  occurrence  in  RIP  of sequence  motifs 
characteristic of protein kinases.  If this protein indeed pos- 
sesses protein kinase activity, it may be capable ofphospho- 
rylating  MORT1  and  TRADD  upon  binding  to  them, 
thereby modulating their  function.  One  plausible  conse- 
quence of the association  of TRADD and MORT1, and of 
the binding of RIP to both proteins, is integration of their 
effects, at least in part.  This integration may account for the 
fact that cell death induction by p55-R and Fas/APO1 ex- 
hibit  certain  similarities  as  well  as  distinct  features;  this 
could also result in sharing of other activities  of the two re- 
ceptors. 
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